openPR Logo
Press release

Personalized Cell Therapy Market Insights, Opportunity Analysis, and Industry Forecast

08-31-2018 04:49 PM CET | Health & Medicine

Press release from: Coherent Market Insights

Personalized Cell Therapy Market Insights, Opportunity

Personalized Cell Therapy – Personalizing Treatment for Improved Outcomes

Individualized treatment for various diseases such as cancer and autoimmune diseases by injecting living cells into a patient’s body is known as personalized cell therapy. Various types of living cells such as mature and immature solid tissue cells, adult stem cells, blood and bone marrow cells, and embryonic stem cells are used for personalized cell therapy. It has various applications such as platelet transfusions, bone marrow transplantation, whole blood transfusions, packed red cell transfusions, and organ transplantation. Due to its ability to treat various diseases, personalized cell therapy has received extensive acceptance among surgeons and patients. It is used to treat neurological diseases such as Parkinson’s disease and amyotrophic lateral sclerosis, spinal cord injuries, diabetes, and cancer.

Request a sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/204

According to Centre for Disease Control (CDC), globally, around 14.1 million people were diagnosed with cancer in 2012, leading to 8.2 million fatalities. It is projected that around 19.3 million new cancer cases will be diagnosed by 2025. Furthermore, as per International Diabetes Federation (IDF), in 2015, over 415 million people suffered from diabetes and this number is expected to reach 642 million by 2040. It is expected that rising prevalence of chronic diseases and rapid spurt in incidence rate of cancer cases will fuel the growth of the global personalized cell therapy market.

The other major factor driving the growth of personalized cell therapy market is increasing government initiatives and funding for stem cell research. For example, in 2015, the National Institutes of Health invested around US$ 1,429 million in stem cell research, as stem cells research offers great potential for better understanding of human development it is expected that this factor will fuel growth of the personalized cell therapy market in the near future.

Increase in development of personalized cell therapy products along with high prevalence of lifestyle diseases driving the growth of personalized cell therapy market in developed regions

Better healthcare amenities along with high adoption rate of new technology for the treatment of cancer in the developed region is expected to boost overall sales of autologous cell therapy products in regions such as North America and Europe. There are over 200 companies engaged in development of personalized cell therapy products in the U.S. alone.

The personalized cell therapy market is expected to gain traction in Europe and Asia-Pacific region, which is supported by improvement in healthcare facilities and growing awareness about the personalized cell therapy in emerging economies such as India and China.

As per American Diabetes Association, prevalence of diabetes has nearly doubled since 1980, from 4.7% to 8.7% in 2014. Furthermore, according to Centers for Disease Control and Prevention (CDC), around 117 million people of U.S. had one or more chronic health conditions as of 2012, also in 2014 around 29.1 million people were suffering from diabetes in the U.S.

The global personalized cell therapy market was valued at US$ 3,536.2 million in 2016 and is expected to witness a robust CAGR of 25.3% during the forecast period (2017 – 2024).

Increased prevalence of inflammatory bowel disease is expected to create significant market opportunity for players in the personalized cell therapy market

Currently, except of few therapies practiced to reduce inflammation and inhibit immune response, there are no curative therapy for inflammatory bowel disease (IBD). As drug therapy is not always effective, research experts have discovered special cells in bone marrow that can be developed into injectable cell therapy to treat IBD.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/204

According to study conducted by Wake Forest School of Medicine in 2016, there are over 1 million people in the U.S. suffering from IBD, which is caused by recurrent diarrhea and is characterized by persistent abdominal pain. IBD comprises various medical conditions such as ulcerative colitis and Crohn's disease. In these diseases, the intestines get damaged and can become red and swollen ulcers. This inadvertently creates a highly conducive environment for growth of the global personalized cell therapy market.

Increased economic burden due to neurological disorders expected to fuel the growth in personalized cell therapy market

In complicated neurological disorders such as multiple sclerosis, stroke or spinal cord injuries, scientist claim that stem cells treatment may be the best option or choice of cure. Stem cells can be replaced with damaged cells or the cells, which are highly mitigated to immune responses even in the central nervous system. There are no successful clinical trials so far, as the scientists are facing hurdles in stem cell therapies, however, the use of embryonic stem cells is still a moral issue in most of the regions, obtaining adult stem cells is difficult to collect or tough to be expanded in a therapeutically sufficient amount.

There are several studies conducted on stem cell or personalized cell therapy to treat neurological disorder and spinal cord injury. For instance, in September 2016, MAPFRE Foundation, announced first clinical trial results on personalized cell therapy in patients with complete and chronic spinal cord injury. The study was to implant mesenchymal stem cells, which can create different types of tissue to treat spinal cord injury. The results obtained, explains the improvement in sensitivity and spasticity (muscle stiffness) in all cases, bowel improvement and bladder control in over 80% of patients. Thus, players in the global personalized cell therapy market are focusing efforts to cater to this large target audience.

Some of the major companies in personalized cell therapy market are Cytori Therapeutics Inc., Bellicum Pharmaceuticals, Inc., Saneron CCEL Therapeutics, Inc., MolMed S.p.A. and Vericel Corporation.

Access Full Summary at: https://www.coherentmarketinsights.com/market-insight/personalized-cell-therapy-market-204

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154
#3200

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Personalized Cell Therapy Market Insights, Opportunity Analysis, and Industry Forecast here

News-ID: 1215218 • Views:

More Releases from Coherent Market Insights

Prebiotics for Dietary Supplements Market See Incredible Growth 2024-2031 | Clasado Biosciences, VW-Ingredients, Shandong Longli Biotechnology Co., Ltd, Prenexus Health., Ingredion, Tata Chemicals Ltd., Yakult Honsha Co., Ltd., Tate & Lyle, Roquette Frèr
Prebiotics for Dietary Supplements Market See Incredible Growth 2024-2031 | Clas …
Coherent Market Insights Published Most recent Prebiotics for Dietary Supplements Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the study considers important factors such as an analysis of the market, a definition of the market, market segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. For achieving incredible growth in business,
DNA Repair Drugs Market Expected to Expand at a Steady 2024-2031 | AstraZeneca Plc., Johnson & Johnson, GlaxoSmithKline plc., Pfizer, Inc., Clovis Oncology Inc., AbbVie Inc., Bristol - Myers Squibb, Merck KGaA, Genentech, Inc., Repare Therapeutics Inc., K
DNA Repair Drugs Market Expected to Expand at a Steady 2024-2031 | AstraZeneca P …
Coherent Market Insights Published Most recent DNA Repair Drugs Market Study by in-depth analysis of the current scenario, the Market size, demand, growth pattern, trends, and forecast. This report on the study considers important factors such as an analysis of the market, a definition of the market, market segmentation, significant trends in the industry, an examination of the competitive landscape, and research methodology. For achieving incredible growth in business, this
Polyethylene Terephthalate (PET) Market 2024-2031: Raw Materials Requirements, Manufacturing Process, Business Plan | Alpek S.A.B de C.V., RTP Company, BASF SE
Polyethylene Terephthalate (PET) Market 2024-2031: Raw Materials Requirements, M …
This comprehensive Report of the Polyethylene Terephthalate (PET) Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. A complete and wide-ranging evaluation of the aspects that drive and restrain market growth is also provided throughout the study. This detailed exploration of the
Chlorine Market 2024-2031: Business Plan, Manufacturing Process, Machinery Requirement | BASF SE, Occidental Chemical Corporation
Chlorine Market 2024-2031: Business Plan, Manufacturing Process, Machinery Requi …
This comprehensive Report of the Chlorine Market provides real information about the statistics and state of the global and regional market. Its scope study extends from the market situation to comparative pricing between the main players, spending in specific market areas, and profits. A complete and wide-ranging evaluation of the aspects that drive and restrain market growth is also provided throughout the study. This detailed exploration of the market size

All 5 Releases


More Releases for Personalized

Personalized Supplement Market Report- Top Players, Types, Applications and Regi …
The Personalized Supplement Market research report presents new recent developments, import-export analysis, trade regulations, value chain optimization, the impact of domestic and Personalized Supplement Market players, analyses opportunities in terms of emerging revenue pockets, and changes in market regulations. Personalized Supplement Market also highlights strategic market growth analysis, market size, category Personalized Supplement Market growths, product approvals, product launches, and geographic expansion in the Personalized Supplement Market. Download FREE PDF of
Prosperfit : your personalized financial fitness platform
We are Prosperfit, an organisation that is here to provide financial education through cognitive technology with our unbiased hand-holding. We are equipped to help individuals from a diverse background to become savvy and are equipped to choose the right action for their financial matters. Our personalised, secure, web based and mobile platforms help the users take the decision with ease and comfort. Prosperfit does not believe in taking commission from
TrendSights Analysis: Personalized Health
ReportsWeb.com published “Personalized Health Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Today's digitally savvy consumers are taking their personal wellbeing into their own hands by using products and services that address their specific health needs and help them "live better." As awareness increases, demand for more
Personalized Cancer Vaccines Market Personalized Cancer Vaccines Clinical Pipeli …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Personalized Vaccine: Trail Towards Cancer 1.1 Prologue to Personalized Cancer Immunotherapy 1.2 Advent of Personalized Cancer Vaccine 2. Perception of Personalized Vaccinomics 2.1 Genetic Heterogeneity by HLA System 2.2 Genesis of Tumor Neoantigens 3. Identification of Tumor Neoantigens 3.1 Conventional Methodologies 3.2 Next Genome Sequencing Approach 4. Development of Personalized Vaccines 4.1 Development
Personalized PCAP touchscreen design
Distec combines multi-touch foil with custom cover glass to create compact touch solutions in countless design variations Distec - leading German specialist for TFT flat screens and system solutions for industrial and multimedia applications - now offers touch screen displays with custom designed projected capacitive (PCAP) touchscreens. "Our modular, compact touch solutions are implemented according to customer requirements," explained Matthias Keller, COO Components at Distec. "Whether a custom colored print or
US Personalized Cancer Genome Sequencing Market
RNCOS has recently added a new Market Research Report titled, “US Personalized Cancer Genome Sequencing Market” to its report gallery. The US personalized cancer Whole-Genome Sequencing market is primarily classified into targeted genome sequencing and Whole-Genome Sequencing. Our report entitled “US Personalized Cancer Genome Sequencing Market” takes into account the Whole-Genome Sequencing services, i.e. one of the most attractive sectors due to its inherent capability of high revenue generation and